Osteoprotegerin (OPG) is a key regulator of bone remodeling. Mutations and variations in the OPG gene cause many human diseases that are characterized by not only skeletal abnormalities but also poorly understood hearing loss: Paget's disease, osteoporosis, and celiac disease. To gain insight into the mechanisms of hearing loss in OPG deficiency, we studied OPG knockout (Opg −/− ) mice. We show that they develop sensorineural hearing loss, in addition to conductive hearing loss due to abnormal middle-ear bones. OPG deficiency caused demyelination and degeneration of the cochlear nerve in vivo. It also activated ERK, sensitized spiral ganglion cells (SGC) to apoptosis, and inhibited proliferation and survival of cochlear stem cells in vitro, which could be rescued by treatment with exogenous OPG, an ERK inhibitor, or bisphosphonate. Our results demonstrate a novel role for OPG in the regulation of SGC survival, and suggest a mechanism for sensorineural hearing loss in OPG deficiency.
Introduction
Osteoprotegerin (OPG), also known as tumor necrosis factor receptor superfamily member 11b (TNFRSF11B), is a key regulator of bone remodeling. It functions as a soluble, neutralizing antagonist that competes with the receptor activator of NF-κB (RANK) on preosteoclasts and osteoclasts for RANK ligand (RANKL) produced by osteoblasts to inhibit osteoclast formation and function (Khosla, 2001; Simonet et al., 1997) . Altered expression of OPG has been described in a variety of human diseases that are associated not only with skeletal abnormalities, but also with hearing loss of poorly understood etiology. Loss of function mutations in the OPG gene account for the majority of cases of Juvenile Paget's disease (Daroszewska and Ralston, 2006; Whyte et al, 2002) , an autosomal recessive osteopathy characterized by a generalized increase in bone turnover leading to widespread skeletal deformities in childhood, bone pain and deafness. Genetic variation at the OPG locus is a risk factor for adult-onset Paget's disease (Daroszewska et al., 2004) and osteoporosis (Richards et al., 2008) . Osteoporosis is associated with otosclerosis (Clayton et al., 2004 ) -a common hearing disorder. Neutralizing autoantibodies against OPG cause the development of high-turnover osteoporosis in celiac disease (Riches et al., 2009) , an autoimmune malabsorptive disorder of the small intestine associated with hearing loss (Hizl et al., 2011) .
In general, hearing loss can be categorized as conductive, due to impaired conduction of sound to the inner ear, or sensorineural, due to the damage of delicate mechanosensory structures in the inner ear, cochlear nerve, or higher order auditory centers. While conductive hearing loss in some OPG-related disorders can be attributed, at least in part, to the abnormal function of middle-ear bones that transmit acoustic vibrations to the inner ear (Daroszewska and Ralston, 2006; Whyte et al., 2002) , mechanisms of sensorineural hearing loss in these disorders are poorly understood (Bahmad and Merchant, 2007; Karosi et al., 2011) .
The OPG null mouse (Opg −/− ) provides a unique opportunity to decipher mechanisms of hearing loss due to a variety of OPG-related human diseases (Bucay et al., 1998; Mizuno et al., 1998) . Opg −/− mice are known to have progressive hearing loss due to the resorption of ossicles in the middle ear (Kanzaki et al., 2009; Zehnder et al., 2005 Zehnder et al., , 2006 ; a recent study suggested an additional sensorineural component (Qin et al., 2010 
